NVIDIA stock slips after close as Huang’s CES 2026 keynote puts NVDA roadmap under the microscope
5 January 2026
2 mins read

NVIDIA stock slips after close as Huang’s CES 2026 keynote puts NVDA roadmap under the microscope

New York, January 5, 2026, 4:09 PM EST — After-hours

  • NVIDIA shares fell 0.6% to $187.75 in Monday’s session, with investors focused on CEO Jensen Huang’s CES keynote.
  • Foxconn, NVIDIA’s biggest server maker, reported record fourth-quarter revenue on AI demand.
  • Next catalyst: NVIDIA’s fourth-quarter fiscal 2026 results on Feb. 25.

NVIDIA Corporation shares ended lower on Monday as investors turned to Chief Executive Jensen Huang’s CES keynote for fresh signals on the chipmaker’s product roadmap and demand outlook. The stock closed down 0.6% at $187.75, with after-hours trading under way after the 4 p.m. EST close.

The moment matters because CES is the first major technology showcase of the year, and NVIDIA sits at the center of AI infrastructure spending. Traders have treated management commentary as a high-frequency readout on whether demand for the company’s newest chips is keeping pace with big-ticket data center buildouts.

It also comes as competition tightens. Rivals are pushing new processors, while major customers are investing in their own in-house silicon to reduce dependence on any single supplier, raising the bar for NVIDIA to keep extending performance gains and justify premium valuations.

Huang was due to take the stage on Monday at the Consumer Electronics Show in Las Vegas, where Reuters said he could offer new details on product plans as competitive pressure rises from both rivals and customers. Reuters also reported NVIDIA is keen to show its latest products can outperform older chips such as the H200, even as debate continues in Washington over chip flows to China. 1

A separate demand signal came from Taiwan’s Foxconn, which reported record fourth-quarter revenue on strong demand for artificial intelligence products. Foxconn, described by Reuters as NVIDIA’s biggest server maker, said quarterly revenue jumped 22.07% from a year earlier to T$2.6028 trillion and flagged continued robust demand for AI server rack products into the first quarter. 2

CES also brings a crowded competitive lineup. Intel is expected to launch its “Panther Lake” laptop chip using its 18A process, a debut investors are watching because it is meant to be Intel’s first high-volume product on that manufacturing technology, Reuters reported. Intel has struggled with “yield” — the share of usable chips per wafer — a key metric for whether new chip processes can scale profitably. 3

Beyond the product cycle, investors are also weighing a macro risk that can hit long-duration growth stocks: inflation and the interest-rate path. “The costs are going up not down in our forecast, because there’s inflation in chip costs and inflation in power costs,” Morgan Stanley strategist Andrew Sheets said, as investors debated whether AI-related spending could add to price pressures. 4

But the setup cuts both ways for NVDA. If Huang’s remarks fail to deliver concrete road-map milestones, or if management tone suggests customers are slowing AI infrastructure orders, momentum could fade quickly; tighter export rules or a sharper shift toward in-house chips by large buyers would amplify that downside.

In the near term, traders will watch for market reaction to any CES headlines and whether broader data shifts rate expectations again. Reuters said attention is also on Friday’s U.S. nonfarm payrolls report, a release that can move bond yields and, in turn, pressure or support megacap tech valuations. 5

The next scheduled company catalyst is NVIDIA’s fourth-quarter fiscal 2026 financial results on Feb. 25, according to its investor relations calendar. Investors will measure results against the company’s prior outlook for fourth-quarter revenue of about $65.0 billion, plus or minus 2%, and listen for updates on supply, margins and the pace of AI data center spending into 2026. 6

Stock Market Today

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

7 February 2026
XRP fell about 5% Saturday to $1.42, extending a 22% weekly drop as thin liquidity and macro jitters drove sharp swings. Bitcoin rebounded above $70,000 after a brief plunge, while ether surged 12%. Ripple outlined plans for an “Institutional DeFi” roadmap, including a new lending protocol and permissioned DEX. The Federal Reserve held rates steady last week, with officials signaling caution on inflation.
Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms
Previous Story

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Micron stock whipsaws as “unprecedented” AI memory shortage tightens supply
Next Story

Micron stock whipsaws as “unprecedented” AI memory shortage tightens supply

Go toTop